This article highlights House Bill 2002, a bill intended to guarantee access to abortion and gender-affirming care. Christina Milano, M.D., said during a hearing last month that coverage would already include people who seek to transition back to their original gender.
Mark Pennesi, M.D., Ph.D., is the lead investigator for a Phase 1/2 clinical trial investigating the safety and tolerability of an experimental treatment for retinitis pigmentosa, which causes vision loss.
In a video interview with OncLive, Alexandra Sokolova, M.D., discusses remaining questions and next steps with PARP inhibitors in the prostate cancer treatment paradigm.
A new study led by Jane Zhu, M.D., suggests Medicaid reimbursement for the same mental health treatment varies dramatically among U.S. states. Zhu says: “Our study confirms that some states are setting these reimbursement rates quite low, which has implications not just for provider acceptance of Medicaid insurance but also the extent to which they see Medicaid patients."
A study by Dan Hartung, Pharm.D., M.P.H., Elizabeth Needham Waddell, Ph.D., and others found people recently released from incarceration face a risk of opioid overdose 10 times greater than the general public, and that the risk is significantly higher within the first two weeks of release.
An Oregon Capital Chronicle article highlights House Bill 2002, a bill intended to guarantee access to abortion and gender-affirming care. Christina Milano, M.D., said during a hearing last month that coverage would already include people who seek to transition back to their original gender.
Christina Milano, M.D., provided testimony about gender-affirming health care to an Oregon legislative committee considering a proposed bill that would expand access to abortion and gender-affirming care in the state.
Following a school shooting in Nashville, KATU-TV asks mental health professionals, crisis professionals and pediatricians are advice on how to discuss the events with schoolchildren. Benjamin Hoffman, M.D., says: "If parents are comfortable talking about it and kids are interested in talking about it, the family should talk about it. If kids aren't ready, it's not a topic that needs to be pushed. Kids will react based on their circumstances and developmental level."
Joint animal research by OHSU, George Washington University and Mabloc, LLC, suggests monoclonal antibody infusions offer a potential cure for serious cases of yellow fever.